The State of the Art in Non–Small Cell Lung Cancer Immunotherapy

Once considered an ineffective modality in lung cancer, immunotherapy has emerged as one of the most promising therapeutic strategies for this lethal disease. The past few years have seen a plethora of clinical trials evaluating various immunotherapeutic approaches in lung cancer. This article discusses the current status of immunotherapy in non–small cell lung cancer with a review of completed studies and ongoing trials.